What is the primary pathophysiologic mechanism driving the progression of chronic heart failure?

What is the primary pathophysiologic mechanism driving the progression of chronic heart failure?

• A. Chronic activation of RAAS and SNS leading to remodeling, edema, and progressive pump failure.
• B. Decreased preload due to diuretic therapy.
• C. Isolated right ventricular failure.
• D. Acute coronary syndrome triggering myocardial injury.

Answer: (A)

The primary mechanism driving progression of chronic heart failure is chronic activation of the RAAS and sympathetic nervous system leading to adverse remodeling and progressive pump failure. When the heart's output falls short, the kidneys sense reduced perfusion and activate the RAAS, causing sodium and water retention, vasoconstriction, and aldosterone-driven fibrosis and remodeling. At the same time, chronic sympathetic activation boosts heart rate and contractility initially but over time promotes myocyte injury, hypertrophy, and further structural changes that worsen contractile function. This neurohormonal loop creates a cycle of worsening dilation, reduced ejection fraction, and edema, fueling ongoing heart failure progression. Diuretic therapy can alleviate symptoms by lowering preload, but it doesn’t halt the underlying remodeling process. The other scenarios describe specific conditions or triggers rather than the sustained, system-wide mechanism driving chronic deterioration.

The primary mechanism driving progression of chronic heart failure is chronic activation of the RAAS and sympathetic nervous system leading to adverse remodeling and progressive pump failure. When the heart's output falls short, the kidneys sense reduced perfusion and activate the RAAS, causing sodium and water retention, vasoconstriction, and aldosterone-driven fibrosis and remodeling. At the same time, chronic sympathetic activation boosts heart rate and contractility initially but over time promotes myocyte injury, hypertrophy, and further structural changes that worsen contractile function. This neurohormonal loop creates a cycle of worsening dilation, reduced ejection fraction, and edema, fueling ongoing heart failure progression. Diuretic therapy can alleviate symptoms by lowering preload, but it doesn’t halt the underlying remodeling process. The other scenarios describe specific conditions or triggers rather than the sustained, system-wide mechanism driving chronic deterioration.